REGENXBIO (RGNX)
(Delayed Data from NSDQ)
$11.68 USD
-0.21 (-1.77%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $11.68 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth D Momentum F VGM
Brokerage Reports
REGENXBIO Inc. [RGNX]
Reports for Purchase
Showing records 61 - 66 ( 66 total )
Company: REGENXBIO Inc.
Industry: Medical - Biomedical and Genetics
IND Cleared for RGX-202/DMD, Phase 1/2 Trial Expected in H1:22
Provider: WEDBUSH SECURITIES INC.
Analyst: ARGYRIDES A
Company: REGENXBIO Inc.
Industry: Medical - Biomedical and Genetics
Company: REGENXBIO Inc.
Industry: Medical - Biomedical and Genetics
One Subretinal/Suprachoroidal Shot at Forever; Initiating at NEUTRAL & $29 PT
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: REGENXBIO Inc.
Industry: Medical - Biomedical and Genetics
Eyes Wide Open: Setting Our Sights on a New Frontier in Ocular Disease
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: REGENXBIO Inc.
Industry: Medical - Biomedical and Genetics
One Subretinal/Suprachoroidal Shot at Forever: Initiating at NEUTRAL & $29 PT
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department